MENU
ALKS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Alkermes (ALKS) Ownership - Who owns Alkermes?

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
1 Burlington Road
Phone
+353 17728000
Employees
2050
Web
https://www.alkermes.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
7.7B
P/E Ratio
114.75
Total Cash
656.58M
Projected Growth
21.57
Total Debt
1.57B
Revenue
1.67B
Risk (Beta)
0.43
Dividend Yield
N/A
Total Cash/Share
3.91
Total Debt/Equity
27.09
Revenue/Share
9.94 USD as % of share price
Who owns Alkermes? ALKS symbol Ownership - Tickeron.com